BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: κ opioid receptor (KOR; OPRK1); opioid receptor δ 1 (OPRD1; DOR)

June 18, 2015 7:00 AM UTC

In vitro and mouse studies suggest diimidazodiazepine-based dual KOR/DOR agonists could help treat pain with fewer side effects than standard opiates. In vitro testing of fused diimidazodiazepine anal...